Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Aliskiren/Amlodipine Combination in Hypertension
NCT00777946Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of aliskiren, amlodipine in essential hypertension, sponsored by Novartis. Started Oct 2008; status: completed.
02
Drugs
aliskirenamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00777946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00777946.